HCPCS Level IIdrugActive
J1746
Inj., ibalizumab-uiyk, 10 mg
BETOS: O1E
Effective: 2019-01-01
Referenced in 1 policies
Description
Injection, ibalizumab-uiyk, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Trogarzo
Manufacturer
Theratechnologies Inc.
HCPCS Dosage
10 MG
Billing Units
20.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.